PARIS (Reuters) – Sanofi raised its 2021 outlook after its vaccines and star eczema treatment Dupixent helped it post better-than-expected second-quarter results on Thursday. The French drugmaker said it was now targeting earnings per share to grow around 12% at constant exchange rates this year. It had previously been expecting a 'high single digit' rise in earnings. (Reporting by Matthias Blamont; Editing by Jacqueline Wong)

https://wkzo.com/2021/07/29/sanofi-raises-profit-forecasts-after-strong-second-quarter/

#wkzo